VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Amikacine
Preclinical
Small molecule
C
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
1
Indications
2
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Nebulization
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Nebulization
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
Nebulization
1 trial
Evaluation of Nebulization and Positive Expiratory Pressure Combination
Unknown status
·
C
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
·
N/A
·
NCT02535130
·
15 enrolled
PPA
1 trial
Which Apparatus for Inhaled Pentamidine?
Unknown status
·
C
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
·
Phase 1
·
NCT02277808
·
10 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Amikacine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Amikacine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Amikacine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Cliniques universitaires Saint-Luc- Université Catholique de Louvain company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
C
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Related News